SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,366.24 773.00
( 1.08%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Amrutanjan Health Care Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

590006

INE098F01031

128.0610499

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMRUTANJAN

23.43

1457.82

EPS(TTM)

Face Value()

Div & Yield %

21.52

0.97

Back

The Bombay Burmah Trading Corporation consolidated net profit rises 19.72% in the June 2026 quarter

Aug 13,2026

Net profit of The Bombay Burmah Trading Corporation rose 19.72% to Rs 288.16 crore in the quarter ended June 2026 as against Rs 240.70 crore during the previous quarter ended June 2025. Sales rose 9.26% to Rs 5052.15 crore in the quarter ended June 2026 as against Rs 4623.77 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5052.15	4623.77	9
OPM %	16.11	15.66	-
PBDT	855.11	763.90	12
PBT	771.82	678.08	14
NP	288.16	240.70	20

72,366.24 773.00 ( 1.08%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)